Mesoblast (MESO) Net Income Growth (3y) (2017 - 2023)
Mesoblast (MESO) Net Income Growth (3y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.89 Bn | 468.10 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 122.12 Bn | 114.87 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | 79.26% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 47.10% |
| 10 | Mesoblast | 18.88 Bn | 18.75 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 9.75% |
| Mar 31, 2023 | 50.33% |
| Dec 31, 2022 | 45.77% |
| Sep 30, 2022 | -45.48% |
| Jun 30, 2022 | -6.30% |
| Mar 31, 2022 | 43.19% |
| Dec 31, 2021 | 47.26% |
| Sep 30, 2021 | -5.11% |
| Jun 30, 2021 | 2.13% |
| Mar 31, 2021 | -17.28% |
| Dec 31, 2020 | -42.49% |
| Sep 30, 2020 | -51.76% |
| Jun 30, 2020 | -2.59% |
| Mar 31, 2020 | 5.90% |
| Dec 31, 2019 | 5.33% |
| Sep 30, 2019 | 34.81% |
| Jun 30, 2019 | 46.83% |
| Mar 31, 2019 | 3.47% |
| Dec 31, 2018 | 0.88% |
| Sep 30, 2018 | -14.00% |